Literature DB >> 19124147

Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems.

Maria Ludovica Saccà1, Cesare Accinelli, Jerker Fick, Richard Lindberg, Björn Olsen.   

Abstract

The antiviral drug Tamiflu (Oseltamivir Phosphate, OP), has been indicated by the World Health Organization as a first-line defense in case of an avian influenza pandemic. Recent studies have demonstrated that Oseltamivir Carboxylate (OC), the active metabolite of the prodrug OP, has the potential to be released into water bodies. The present laboratory study focused on basic processes governing the environmental fate of OC in surface water from two contrasting aquatic ecosystems of northern Italy, the River Po and the Venice lagoon. Results of this study confirmed the potential of OC to persist in surface water. However, addition of 5% of sediments resulted in rapid OC degradation. Estimated half-life of OC in water/sediment of the River Po was 15 days. After three weeks of incubation at 20 degrees C, more than 8% of (14)C-OC evolved as (14)CO(2) from water/sediment samples of the River Po and Venice lagoon. At the end of the 21-day incubation period, more than 65% of the (14)C-residues were recovered from the liquid phase of both Po and Venice water/sediment samples. OC was moderately retained onto coarse sediments from the two sites. In water/sediment samples of the River Po and Venice lagoon treated with (14)C-OC, more than 30% of the (14)C-residues remained water-extractable after three weeks of incubation. The low affinity of OC to sediments suggests that presence of sediments would not reduce its bioavailability to microbial degradation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124147     DOI: 10.1016/j.chemosphere.2008.11.060

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  14 in total

1.  Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir.

Authors:  Terri D Stoner; Scott Krauss; Jasmine C M Turner; Patrick Seiler; Nicholas J Negovetich; David E Stallknecht; Sharon Frase; Elena A Govorkova; Robert G Webster
Journal:  Antiviral Res       Date:  2012-01-10       Impact factor: 5.970

2.  Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.

Authors:  Jenna E Achenbach; Richard A Bowen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

3.  Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds.

Authors:  Goran Orozovic; Kanita Orozovic; Johan Lennerstrand; Björn Olsen
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

4.  Exposure of the main italian river basin to pharmaceuticals.

Authors:  Federico Ferrari; Agata Gallipoli; Matteo Balderacchi; Maria M Ulaszewska; Ettore Capri; Marco Trevisan
Journal:  J Toxicol       Date:  2011-09-19

5.  Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.

Authors:  Josef D Järhult; Shaman Muradrasoli; John Wahlgren; Hanna Söderström; Goran Orozovic; Gunnar Gunnarsson; Caroline Bröjer; Neus Latorre-Margalef; Jerker Fick; Roman Grabic; Johan Lennerstrand; Jonas Waldenström; Ake Lundkvist; Björn Olsen
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

6.  Assessing the ecotoxicologic hazards of a pandemic influenza medical response.

Authors:  Andrew C Singer; Vittoria Colizza; Heike Schmitt; Johanna Andrews; Duygu Balcan; Wei E Huang; Virginie D J Keller; Alessandro Vespignani; Richard J Williams
Journal:  Environ Health Perspect       Date:  2011-03-02       Impact factor: 9.031

7.  Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan.

Authors:  Takashi Azuma; Hirotaka Ishiuchi; Tomomi Inoyama; Yusuke Teranishi; Misato Yamaoka; Takaji Sato; Naoyuki Yamashita; Hiroaki Tanaka; Yoshiki Mino
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

8.  Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.

Authors:  Gopal C Ghosh; Norihide Nakada; Naoyuki Yamashita; Hiroaki Tanaka
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

9.  Compliance to oseltamivir among two populations in Oxfordshire, United Kingdom affected by influenza A(H1N1)pdm09, November 2009--a waste water epidemiology study.

Authors:  Andrew C Singer; Josef D Järhult; Roman Grabic; Ghazanfar A Khan; Ganna Fedorova; Jerker Fick; Richard H Lindberg; Michael J Bowes; Björn Olsen; Hanna Söderström
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  Detection of the antiviral drug oseltamivir in aquatic environments.

Authors:  Hanna Söderström; Josef D Järhult; Björn Olsen; Richard H Lindberg; Hiroaki Tanaka; Jerker Fick
Journal:  PLoS One       Date:  2009-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.